Longitudinal evaluation of PROMIS-29 and FACIT-Dyspnea short forms in systemic sclerosis

Journal of Rheumatology

Volumn 42, Issue 1, 2015, Pages 64-72

  Hinchcliff, Monique E ^a,d   Beaumont, Jennifer L ^a   Carns, Mary A ^a,d   Podlusky, Sofia ^a,d   Thavarajah, Krishna ^d   Varga, John ^a   Cella, David ^a   Chang, Rowland W ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Medical Social Sciences Institute for Public Health and Medicine Northwestern University Feinberg School of Medicine ^*  (United States)

^c Institute for Public Health and Medicine   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

FACIT; Health status; PROMIS; Severity index; Systemic sclerosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY ASSESSMENT; DYSPNEA; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-DYSPNEA 10 ITEM SHORT FORM; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL DYSPNEA SCORE; PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM 29 ITEM HEALTH PROFILE; PHYSICAL ACTIVITY; SENSITIVITY ANALYSIS; SHORT FORM 36; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYSTEMIC SCLEROSIS; VALIDITY; COMPLICATION; DISABILITY; MIDDLE AGED; PATHOPHYSIOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; DISABILITY EVALUATION; DYSPNEA; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84920430122     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140143     Document Type: Article

References (22)

1. Hinchcliff M, Beaumont JL, Thavarajah K, Varga J, Chung A, Podlusky S, et al. Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-Item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form. Arthritis Care Res 2011;63:1620-8.
2. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007;45:S3-S11.
3. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010;63:1179-94.
4. Choi SW, Victorson DE, Yount S, Anton S, Cella D. Development of a conceptual framework and calibrated item banks to measure patient-reported dyspnea severity and related functional limitations. Value Health 2011;14:291-306.
5. Yount SE, Choi SW, Victorson D, Ruo B, Cella D, Anton S, et al. Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD). Value Health 2011;14:307-15.
6. Khanna D, Maranian P, Rothrock N, Cella D, Gershon R, Khanna PP, et al. Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic. Value Health 2012;15:128-34.
7. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
8. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737-47.
9. Bjorner JB, Rose M, Gandek B, Stone AA, Junghaenel DU, Ware JE Jr. Difference in method of administration did not significantly impact item response: An IRT-based analysis from the Patient- Reported Outcomes Measurement Information System (PROMIS) initiative. Qual Life Res 2014;23:217-27.
10. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999;26:2159-67.
11. Hinchcliff ME, Just E, Podlusky S, Varga J, Chang RW, Kibbe WA. Text data extraction for a prospective, research-focused data mart: implementation and validation. BMC Med Inform Decis Mak 2012;12:106.
12. Victorson DE, Anton S, Hamilton A, Yount S, Cella D. A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease. Value Health 2009;12:1018-25.
13. Amjadi S, Maranian P, Furst DE, Clements PJ, Wong WK, Postlethwaite AE, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: Analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum 2009;60:2490-8.
14. Yost KJ, Eton DT. Combining distribution- And anchor-based approaches to determine minimally important differences: The FACIT experience. Eval Health Prof 2005;28:172-91.
15. Yost KJ, Eton DT, Garcia SF, Cella D. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol 2011;64:507-16.
16. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5.
17. Shanmugam VK, Steen VD. Renal disease in scleroderma: An update on evaluation, risk stratification, pathogenesis and management. Curr Opin Rheumatol 2012;24:669-76.
18. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:14S-34S.
19. Krampe H, Bartels C, Victorson D, Enders CK, Beaumont J, Cella D, et al. The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotroph Lateral Scler 2008;9:99-107.
20. Yount S, Beaumont J, Rosenbloom S, Cella D, Patel J, Hensing T, et al. A brief symptom index for advanced lung cancer. Clin Lung Cancer 2012;13:14-23.
21. Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832-40.
22. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91.